CTI BIOPHARMA CORP Quarterly Return On Assets in % from Q1 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cti Biopharma Corp quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q1 2023.
  • Cti Biopharma Corp Return On Assets for the quarter ending March 31, 2023 was -55.8 %, a 54.7% increase year-over-year.
  • Cti Biopharma Corp annual Return On Assets for 2022 was -72.2 %, a 45.8% increase from 2021.
  • Cti Biopharma Corp annual Return On Assets for 2021 was -133 %, a 81.4% decline from 2020.
  • Cti Biopharma Corp annual Return On Assets for 2020 was -73.4 %, a 13.2% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -55.8 +67.4 +54.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -72.2 +61.1 +45.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -97.3 +11.6 +10.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -110 -5.27 -5.04% Apr 1, 2022 Jun 30, 2022
Q1 2022 -123 -27.5 -28.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -133 -59.8 -81.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -109 -42.2 -63.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -105 -38.7 -58.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -95.7 -31.8 -49.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -73.4 -8.59 -13.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -66.7 -24 -56.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -66 -21.5 -48.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -63.9 -23.5 -58.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -64.8 -35.4 -120% Oct 1, 2019 Dec 31, 2019
Q3 2019 -42.7 +6.31 +12.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -44.5 +4.64 +9.45% Apr 1, 2019 Jun 30, 2019
Q1 2019 -40.4 -9.53 -30.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -29.5 +35.2 +54.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -49 +1.37 +2.72% Jul 1, 2018 Sep 30, 2018
Q2 2018 -49.1 +24.6 +33.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -30.8 +75.5 +71% Jan 1, 2018 Mar 31, 2018
Q4 2017 -64.7 -7.14 -12.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -50.4 +14.2 +22% Jul 1, 2017 Sep 30, 2017
Q2 2017 -73.7 -3.96 -5.68% Apr 1, 2017 Jun 30, 2017
Q1 2017 -106 -19.8 -22.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -57.6 +81.4 +58.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 -64.5 +121 +65.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -69.7 +62.3 +47.2% Apr 1, 2016 Jun 30, 2016
Q1 2016 -86.6 +46.6 +35% Jan 1, 2016 Mar 31, 2016
Q4 2015 -139 -9.88 -7.66% Oct 1, 2015 Dec 31, 2015
Q3 2015 -185 -128 -224% Jul 1, 2015 Sep 30, 2015
Q2 2015 -132 -40.4 -44% Apr 1, 2015 Jun 30, 2015
Q1 2015 -133 -53.7 -67.5% Jan 1, 2015 Mar 31, 2015
Q4 2014 -129 -62.1 -92.8% Oct 1, 2014 Dec 31, 2014
Q3 2014 -57.2 +64.3 +52.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -91.7 +35.3 +27.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -79.5 +114 +58.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -66.9 +144 +68.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 -122 +81.3 +40.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -127 +52.7 +29.4% Apr 1, 2013 Jun 30, 2013
Q1 2013 -194 -87.2 -81.9% Jan 1, 2013 Mar 31, 2013
Q4 2012 -211 Oct 1, 2012 Dec 31, 2012
Q3 2012 -203 Jul 1, 2012 Sep 30, 2012
Q2 2012 -180 Apr 1, 2012 Jun 30, 2012
Q1 2012 -106 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.